September 2017 - Volume 32 - Issue 5 - Contributor Index

Alphabetical Search
I
J
N
O
Q
U
X
Author:
Zhang, Min

Long-term function and psychosocial outcomes with venlafaxine extended release 75–225 mg/day versus placebo in the PREVENT study

Watanabe, Koichiro; Thase, Michael E.; Kikuchi, Toshiaki; More

International Clinical Psychopharmacology . 32(5):271-280, September 2017.

Author:
Yu, Nan-Wen
Author:
Yehya, Arij
Author:
Wu, Chi-Shin

Long-term function and psychosocial outcomes with venlafaxine extended release 75–225 mg/day versus placebo in the PREVENT study

Watanabe, Koichiro; Thase, Michael E.; Kikuchi, Toshiaki; More

International Clinical Psychopharmacology . 32(5):271-280, September 2017.

Author:
Wang, Sheng-Min

Comparison between long-acting injectable aripiprazole versus paliperidone palmitate in the treatment of schizophrenia: systematic review and indirect treatment comparison

Pae, Chi-Un; Wang, Sheng-Min; Han, Changsu; More

International Clinical Psychopharmacology . 32(5):235-248, September 2017.

Author:
Tsuboi, Takashi

Long-term function and psychosocial outcomes with venlafaxine extended release 75–225 mg/day versus placebo in the PREVENT study

Watanabe, Koichiro; Thase, Michael E.; Kikuchi, Toshiaki; More

International Clinical Psychopharmacology . 32(5):271-280, September 2017.

Author:
Tsai, Hui-Ju

Long-term function and psychosocial outcomes with venlafaxine extended release 75–225 mg/day versus placebo in the PREVENT study

Watanabe, Koichiro; Thase, Michael E.; Kikuchi, Toshiaki; More

International Clinical Psychopharmacology . 32(5):271-280, September 2017.

Effects of vilazodone on suicidal ideation and behavior in adults with major depressive disorder or generalized anxiety disorder: post-hoc analysis of randomized, double-blind,...

Thase, Michael E.; Edwards, John; Durgam, Suresh; More

International Clinical Psychopharmacology . 32(5):281-288, September 2017.

Author:
Suhre, Karsten

Comparison between long-acting injectable aripiprazole versus paliperidone palmitate in the treatment of schizophrenia: systematic review and indirect treatment comparison

Pae, Chi-Un; Wang, Sheng-Min; Han, Changsu; More

International Clinical Psychopharmacology . 32(5):235-248, September 2017.

Comparison between long-acting injectable aripiprazole versus paliperidone palmitate in the treatment of schizophrenia: systematic review and indirect treatment comparison

Pae, Chi-Un; Wang, Sheng-Min; Han, Changsu; More

International Clinical Psychopharmacology . 32(5):235-248, September 2017.

Long-term function and psychosocial outcomes with venlafaxine extended release 75–225 mg/day versus placebo in the PREVENT study

Watanabe, Koichiro; Thase, Michael E.; Kikuchi, Toshiaki; More

International Clinical Psychopharmacology . 32(5):271-280, September 2017.

Author:
Pae, Chi-Un

Comparison between long-acting injectable aripiprazole versus paliperidone palmitate in the treatment of schizophrenia: systematic review and indirect treatment comparison

Pae, Chi-Un; Wang, Sheng-Min; Han, Changsu; More

International Clinical Psychopharmacology . 32(5):235-248, September 2017.

Author:
Mathews, Maju

Effects of vilazodone on suicidal ideation and behavior in adults with major depressive disorder or generalized anxiety disorder: post-hoc analysis of randomized, double-blind,...

Thase, Michael E.; Edwards, John; Durgam, Suresh; More

International Clinical Psychopharmacology . 32(5):281-288, September 2017.

Comparison between long-acting injectable aripiprazole versus paliperidone palmitate in the treatment of schizophrenia: systematic review and indirect treatment comparison

Pae, Chi-Un; Wang, Sheng-Min; Han, Changsu; More

International Clinical Psychopharmacology . 32(5):235-248, September 2017.

Author:
Mahfoud, Ziyad
Author:
Lee, Soo-Jung

Comparison between long-acting injectable aripiprazole versus paliperidone palmitate in the treatment of schizophrenia: systematic review and indirect treatment comparison

Pae, Chi-Un; Wang, Sheng-Min; Han, Changsu; More

International Clinical Psychopharmacology . 32(5):235-248, September 2017.

Long-term function and psychosocial outcomes with venlafaxine extended release 75–225 mg/day versus placebo in the PREVENT study

Watanabe, Koichiro; Thase, Michael E.; Kikuchi, Toshiaki; More

International Clinical Psychopharmacology . 32(5):271-280, September 2017.

Long-term function and psychosocial outcomes with venlafaxine extended release 75–225 mg/day versus placebo in the PREVENT study

Watanabe, Koichiro; Thase, Michael E.; Kikuchi, Toshiaki; More

International Clinical Psychopharmacology . 32(5):271-280, September 2017.

Author:
Huang, Chih-Wan
Author:
Hani, Yahya
Author:
Han, Changsu

Comparison between long-acting injectable aripiprazole versus paliperidone palmitate in the treatment of schizophrenia: systematic review and indirect treatment comparison

Pae, Chi-Un; Wang, Sheng-Min; Han, Changsu; More

International Clinical Psychopharmacology . 32(5):235-248, September 2017.

Effects of vilazodone on suicidal ideation and behavior in adults with major depressive disorder or generalized anxiety disorder: post-hoc analysis of randomized, double-blind,...

Thase, Michael E.; Edwards, John; Durgam, Suresh; More

International Clinical Psychopharmacology . 32(5):281-288, September 2017.

Author:
for GROUP
Author:
Emsley, Robin

Comparison between long-acting injectable aripiprazole versus paliperidone palmitate in the treatment of schizophrenia: systematic review and indirect treatment comparison

Pae, Chi-Un; Wang, Sheng-Min; Han, Changsu; More

International Clinical Psychopharmacology . 32(5):235-248, September 2017.

Author:
Edwards, John

Effects of vilazodone on suicidal ideation and behavior in adults with major depressive disorder or generalized anxiety disorder: post-hoc analysis of randomized, double-blind,...

Thase, Michael E.; Edwards, John; Durgam, Suresh; More

International Clinical Psychopharmacology . 32(5):281-288, September 2017.

Author:
Durgam, Suresh

Effects of vilazodone on suicidal ideation and behavior in adults with major depressive disorder or generalized anxiety disorder: post-hoc analysis of randomized, double-blind,...

Thase, Michael E.; Edwards, John; Durgam, Suresh; More

International Clinical Psychopharmacology . 32(5):281-288, September 2017.

Author:
de Wit, Iris E.
Author:
de Haan, Lieuwe
Author:
Chiu, Yu-Wen
Author:
Chen, Pei-Jung

Effects of vilazodone on suicidal ideation and behavior in adults with major depressive disorder or generalized anxiety disorder: post-hoc analysis of randomized, double-blind,...

Thase, Michael E.; Edwards, John; Durgam, Suresh; More

International Clinical Psychopharmacology . 32(5):281-288, September 2017.

Effects of vilazodone on suicidal ideation and behavior in adults with major depressive disorder or generalized anxiety disorder: post-hoc analysis of randomized, double-blind,...

Thase, Michael E.; Edwards, John; Durgam, Suresh; More

International Clinical Psychopharmacology . 32(5):281-288, September 2017.

Author:
Cerri, Cesare

Long-term function and psychosocial outcomes with venlafaxine extended release 75–225 mg/day versus placebo in the PREVENT study

Watanabe, Koichiro; Thase, Michael E.; Kikuchi, Toshiaki; More

International Clinical Psychopharmacology . 32(5):271-280, September 2017.

Author:
Bini, Silvia
Author:
Bahk, Won-Myong

Comparison between long-acting injectable aripiprazole versus paliperidone palmitate in the treatment of schizophrenia: systematic review and indirect treatment comparison

Pae, Chi-Un; Wang, Sheng-Min; Han, Changsu; More

International Clinical Psychopharmacology . 32(5):235-248, September 2017.

Author:
Asami, Yuko

Long-term function and psychosocial outcomes with venlafaxine extended release 75–225 mg/day versus placebo in the PREVENT study

Watanabe, Koichiro; Thase, Michael E.; Kikuchi, Toshiaki; More

International Clinical Psychopharmacology . 32(5):271-280, September 2017.

Author:
Al-Amin, Hassen
1 2 3 4 5